CoChat

A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder

Open access
Menchón, José M., Real, Eva, Alonso, Pino, Aparicio, Marco Alberto, Segalas, Cinto, Plans, Gerard, Luyten, Laura, Brunfaut, Els, Matthijs, Laurean, Raymakers, Simon, Bervoets, Chris, Higueras, Antonio, Katati, Majed, Guerrero, José, Hurtado, Mariena, Prieto, Mercedes, Stieglitz, Lennart H., Löffelholz, Georg, Walther, Sebastian, Pollo, Claudio, Zurowski, Bartosz, Tronnier, Volker, Kordon, Andreas, Gambini, Orsola, Ranieri, Rebecca, Franzini, Angelo, Messina, Giuseppe, Radu-Djurfeldt, Diana, Schechtmann, Gaston, Chen, Long-Long, Eitan, Renana, Israel, Zvi, Bergman, Hagai, Brelje, Tim, Brionne, Thomas C., Conseil, Aurélie, Gielen, Frans, Schuepbach, Michael, Nuttin, Bart, Gabriëls, Loes · 2021 · Molecular Psychiatry
Cited by 94

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Deep brain stimulation (DBS) has been proposed for severe, chronic, treatment-refractory obsessive-compulsive disorder (OCD) patients. Although serious adverse events can occur, only a few studies report on the safety profile of DBS for psychiatric disorders. In a prospective, open-label, interventional multi-center study, we examined the safety and efficacy of electrical stimulation in 30 patients with DBS electrodes bilaterally implanted in the anterior limb of the internal capsule. Safety, efficacy, and functionality assessments were performed at 3, 6, and 12 months post implant. An independent Clinical Events Committee classified and coded all adverse events (AEs) according to EN ISO14155:2011. All patients experienced AEs (195 in total), with the majority of these being mild (52% of all AEs) or moderate (37%). Median time to resolution was 22 days for all AEs and the etiology with the highest AE incidence was ‘programming/stimulation’ (in 26 patients), followed by ‘New illness, injury, condition’ (13 patients) and ‘pre-existing condition, worsening or exacerbation’ (11 patients). Sixteen patients reported a total of 36 serious AEs (eight of them in one single patient), mainly transient anxiety and affective symptoms worsening (20 SAEs). Regarding efficacy measures, Y-BOCS reduction was 42% at 12 months and the responder rate was 60%. Improvements in GAF, CGI, and EuroQol-5D index scores were also observed. In sum, although some severe AEs occurred, most AEs were mild or moderate, transient and related to programming/stimulation and tended to resolve by adjustment of stimulation. In a severely treatment-resistant population, this open-label study supports that the potential benefits outweigh the potential risks of DBS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0562-6

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 94

Metadata

Authors
Menchón, J. M., Real, E., Alonso, P., Aparicio, M. A., Segalas, C., Plans, G., Luyten, L., Brunfaut, E., Matthijs, L., Raymakers, S., Bervoets, C., Higueras, A., Katati, M., Guerrero, J., Hurtado, M., Prieto, M., Stieglitz, L. H., Löffelholz, G., Walther, S., Pollo, C., Zurowski, B., Tronnier, V., Kordon, A., Gambini, O., Ranieri, R., Franzini, A., Messina, G., Radu-Djurfeldt, D., Schechtmann, G., Chen, L.-L., Eitan, R., Israel, Z., Bergman, H., Brelje, T., Brionne, T. C., Conseil, A., Gielen, F., Schuepbach, M., Nuttin, B., & Gabriëls, L.
Venue
Molecular Psychiatry
Published
2019-10-29
Volume
26
Issue
4
Pages
1234-1247
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2982520445
Cited by
94
References
13
FWCI
6.14
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder. https://app.cochat.ai/papers/10.1038/s41380-019-0562-6
The paper
Menchón, J. M., Real, E., Alonso, P., Aparicio, M. A., Segalas, C., Plans, G., Luyten, L., Brunfaut, E., Matthijs, L., Raymakers, S., Bervoets, C., Higueras, A., Katati, M., Guerrero, J., Hurtado, M., Prieto, M., Stieglitz, L. H., Löffelholz, G., Walther, S., . . . Gabriëls, L. (2021). A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder. Molecular Psychiatry. https://doi.org/10.1038/s41380-019-0562-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.